Chromophobe Renal Cell Carcinoma — Trials

Chromophobe Renal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

14 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 13%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06339138	Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study	completed	—	589	Mayo ClinicOTHER	1	Jul 1, 2026	clinicaltrials
NCT03685448	ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)(UNICAB)	completed	Phase 2	35	Australian and New Zealand Urogenital and Prostate Cancer Trials GroupOTHER